Neuralstem

CUR:NAS

Biotechnology

Market Cap

—

MICRO cap

Share Price ←

(—)

YTD Return ←

—

since start of 2020

P/E Ratio

—

Corporate Values

Carbon Footprint
Pollution Prevention
Water Conservation
Data & Privacy Protection
Consumer Health, Wellness & Safety
Employee Ownership, Satisfaction, Benefits & Pay
Workplace Health and Safety
Integrity of Corporate Governance
Ethical Practices
Usage of Conflict Materials
Forced Labor
Diversity of Corporate Leadership

About

Biotechnology Founded 1996

Neuralstem, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of central nervous system therapies based on human neuronal stem cells and small molecule compounds. Its pipeline includes NSI-189 small molecule program, NSI-566 stem cell therapy program, and novel and proprietary chemical entity screening platform. The company was founded by I. Richard Garr, Karl Y. Johe, and Merrill Solomon in 1996 and is headquartered in Germantown, MD.

website

Headquarters

2nd floor

20271 Goldenrod Lane

Germantown, MD 20876

1.301.366.4960

Executives

Name	Title	Gender
I. Richard Garr	Founder	Male
Karl Y. Johe, PhD	Chief Scientific Officer	Male
Merrill Solomon	Founder	Male
Danielle Spangler	Investor Relations Contact	Female
Richard J. Daly, MBA	Chairman, President, Chief Executive Officer & CFO	Male

Mindful Investing Summary

Carbon Footprint

— N/A
Pollution Prevention

— N/A
Water Conservation

— N/A
Data & Privacy Protection

— N/A
Consumer Health, Wellness & Safety

— N/A
Employee Ownership, Satisfaction, Benefits & Pay

— N/A
Workplace Health and Safety

— N/A
Integrity of Corporate Governance

— N/A
Ethical Practices

— N/A
Usage of Conflict Materials

— N/A
Forced Labor

— N/A
Diversity of Corporate Leadership

— N/A

Neuralstem - Competitors and Related Companies

How Neuralstem stacks up to its peers in the Biotechnology industry or with competing business segments.